Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis

FASEB Journal

Volumn 28, Issue 12, 2014, Pages 5136-5147

  Heinrichs, Daniel ^a   Berres, Marie Luise ^a,c   Coeuru, Melanie ^a   Knauel, Meike ^a   Nellen, Andreas ^a   Fischer, Petra ^a   Philippeit, Claudia ^a   Bucala, Richard ^b   Trautwein, Christian ^a   Wasmuth, Hermann E ^a,d   Bernhagen, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Department of Oncological Sciences Mt Sinai School of Medicine ^*  (Germany)

Author keywords

Cytokines; Fatty liver; Hepatic fibrosis; Hepatocyte; Inflammation

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ARGINASE 1; ASPARTATE AMINOTRANSFERASE; CD74 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FAS ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; METFORMIN; OLEIC ACID; PROTEIN; PROTEIN ACC; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS LXRA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PRIMER DNA;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; FAT INTAKE; FATTY ACID SYNTHESIS; FLOW CYTOMETRY; FOOD INTAKE; GENE DELETION; GENE EXPRESSION; HEPATITIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LIPID LIVER LEVEL; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; LIVER CELL; LIVER FATTY DEGENERATION; LIVER PROTECTION; LIVER WEIGHT; MACROPHAGE; METABOLIC SYNDROME X; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84919708689     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-256776     Document Type: Article

References (45)

1. Farrell, G. C., and Larter, C. Z. (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112
2. Cusi, K. (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142, 711-725 e716
3. Fujii, H., and Kawada, N. (2012) Inflammation and fibrogenesis in steatohepatitis. J. Gastroenterol. 47, 215-225
4. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351
5. Agarwal, N., and Sharma, B. C. (2005) Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). Hepatol. Res. 33, 92-96
6. Walenbergh, S. M., Koek, G. H., Bieghs, V., and Shiri-Sverdlov, R. (2013) Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J. Hepatol. 58, 801-810
7. Lee, Y. H., and Pratley, R. E. (2005) The evolving role of inflammation in obesity and the metabolic syndrome. Curr. Diabetes Rep. 5, 70-75
8. Schaffler, A., Scholmerich, J., and Buchler, C. (2005) Mechanisms of disease: Adipocytokines and visceral adipose tissueemerging role in nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 273-280
9. Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., Cheetham, C. H., Earley, A. R., Barnett, A. H., Prins, J. B., and O'Rahilly, S. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908
10. Asare, Y., Schmitt, M., and Bernhagen, J. (2013) The vascular biology of macrophage migration inhibitory factor (MIF): Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb. Haemost. 109, 391-398
11. Calandra, T., and Roger, T. (2003) Macrophage migration inhibitory factor: A regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800
12. Zernecke, A., Bernhagen, J., and Weber, C. (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117, 1594-1602
13. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596
14. Borghese, F., and Clanchy, F. I. (2011) CD74: An emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin. Ther. Targets 15, 237-251
15. Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., and Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476
16. Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., and Young, L. H. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451, 578-582
17. Morand, E. F., Leech, M., and Bernhagen, J. (2006) MIF: A new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399-410
18. Bacher, M., Meinhardt, A., Lan, H. Y., Mu, W., Metz, C. N., Chesney, J. A., Calandra, T., Gemsa, D., Donnelly, T., Atkins, R., and Bucala, R. (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 15, 235-246
19. Assis, D. N., Leng, L., Du, X., Zhang, C. K., Grieb, G., Merk, M., Garcia, A. B., McCrann, C., Chapiro, J., Meinhardt, A., Mizue, Y., Nikolic-Paterson, D. J., Bernhagen, J., Kaplan, M. M., Zhao, H., Boyer, J. L., and Bucala, R. (2014) The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology 59, 580-591
20. Nanji, A. A., Lau, G. K., Tipoe, G. L., Yuen, S. T., Chen, Y. X., Thomas, P., and Lan, H. Y. (2001) Macrophage migration inhibitory factor expression in male and female ethanol-fed rats. J. Interferon Cytokine Res. 21, 1055-1062
21. Hori, Y., Sato, S., Yamate, J., Kurasaki, M., Nishihira, J., Hosokawa, T., Fujita, H., and Saito, T. (2003) Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide. Eur. J. Histochem. 47, 317-324
22. Barnes, M. A., McMullen, M. R., Roychowdhury, S., Pisano, S. G., Liu, X., Stavitsky, A. B., and Nagy, L. E. (2013) Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 57, 1980-1991
23. Heinrichs, D., Knauel, M., Offermanns, C., Berres, M. L., Nellen, A., Leng, L., Schmitz, P., Bucala, R., Trautwein, C., Weber, C., Bernhagen, J., and Wasmuth, H. E. (2011) Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc. Natl. Acad. Sci. U. S. A. 108, 17444-17449
24. Tanaka, Y., Aleksunes, L. M., Yeager, R. L., Gyamfi, M. A., Esterly, N., Guo, G. L., and Klaassen, C. D. (2008) NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 325, 655-664
25. Berres, M. L., Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., Schmitz, P., Streetz, K. L., Berg, T., Gassler, N., Weiskirchen, R., Proudfoot, A., Weber, C., Trautwein, C., and Wasmuth, H. E. (2010) Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J. Clin. Invest. 120, 4129-4140
26. Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., and Seki, E. (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139, 323-334 e327
27. Sahin, H., Trautwein, C., and Wasmuth, H. E. (2010) Functional role of chemokines in liver disease models. Nat. Rev. Gastroenterol. Hepatol. 7, 682-690
28. Day, C. P. (2002) NASH-related liver failure: one hit too many? Am. J. Gastroenterol. 97, 1872-1874
29. Ikeda, D., Sakaue, S., Kamigaki, M., Ohira, H., Itoh, N., Ohtsuka, Y., Tsujino, I., and Nishimura, M. (2008) Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells. Endocrinology 149, 6037-6042
30. Kabir, S. M., Lee, E. S., and Son, D. S. (2014) Chemokine network during adipogenesis in 3T3-L1 cells: Differential response between growth and proinflammatory factor in preadipocytes vs. adipocytes. Adipocyte 3, 97-106
31. Endo, M., Masaki, T., Seike, M., and Yoshimatsu, H. (2007) TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp. Biol. Med. (Maywood) 232, 614-621
32. Kim, J. Y., Song, E. H., Lee, H. J., Oh, Y. K., Choi, K. H., Yu, D. Y., Park, S. I., Seong, J. K., and Kim, W. H. (2010) HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J. Mol. Biol. 397, 917-931
33. Takahashi, Y., Soejima, Y., and Fukusato, T. (2012) Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 18, 2300-2308
34. Rinella, M. E., Elias, M. S., Smolak, R. R., Fu, T., Borensztajn, J., and Green, R. M. (2008) Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 49, 1068-1076
35. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830
36. Chandran, M., Phillips, S. A., Ciaraldi, T., and Henry, R. R. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26, 2442-2450
37. Trayhurn, P. (2013) Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93, 1-21
38. Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S., and Cooper, G. J. (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91-100
39. Murray, P. J., and Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737
40. Sica, A., and Mantovani, A. (2012) Macrophage plasticity and polarization: In vivo veritas. J. Clin. Invest. 122, 787-795
41. Yaddanapudi, K., Putty, K., Rendon, B. E., Lamont, G. J., Faughn, J. D., Satoskar, A., Lasnik, A., Eaton, J. W., and Mitchell, R. A. (2013) Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. J. Immunol. 190, 2984-2993
42. Verschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J., Ouwens, D. M., van Erk, M., de Vries-van der Weij, J., Leng, L., van Bockel, J. H., van Dijk, K. W., Fingerle-Rowson, G., Bucala, R., and Kleemann, R. (2009) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ. Res. 105, 99-107
43. Ricchi, M., Odoardi, M. R., Carulli, L., Anzivino, C., Ballestri, S., Pinetti, A., Fantoni, L. I., Marra, F., Bertolotti, M., Banni, S., Lonardo, A., Carulli, N., and Loria, P. (2009) Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 24, 830-840
44. Bijland, S., Mancini, S. J., and Salt, I. P. (2013) Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin. Sci. (Lond.) 124, 491-507
45. Sozio, M. S., Liangpunsakul, S., and Crabb, D. (2010) The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin. Liver Dis. 30, 378-390